Champiat Stephane - Gustave Roussy | 人才画像

基本信息

浏览量：126

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 245 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors

Laurent Mathiot,David Combarel, Justin Cagnat, Julia Delahousse,Kaissa Ouali,Aurelien Marabelle,Yohann Loriot,Santiago Ponce,Stephane Champiat,Sophie Broutin,Francois-Xavier Danlos

Journal for immunotherapy of cancerno. 5 (2024)

引用0浏览0WOS引用

Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations

Layal Rached,Ariane Laparra,Madona Sakkal,François-Xavier Danlos,Fabrice Barlesi, Franck Carbonnel,Eleonora De Martin,Michel Ducreux,Caroline Even, Jerome Le Pavec,Jean-Marie Michot, Joana MRibeiro,

Cancer Treatment Reviews (2024): 102751-102751

引用0浏览0WOS引用

Impact of Clonal Hematopoiesis-Associated Mutations in Phase I Patients Treated for Solid Tumors: An Analysis of the STING Trial

Julieta Rodriguez, Capucine Baldini,Arnaud Bayle,Arnaud Pages, François Xavier Danlos,Damien Vasseur, Etienne Rouleau, Ludovic Lacroix, Beatriz Alonso de Castro,Vincent Goldschmidt, Lauren Seknazi,Antoine Hollebecque,

JCO precision oncologyno. 8 (2024): e2300631-e2300631

引用0浏览0WOS引用

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors

Laurent Mathiot,David Combarel, Justin Cagnat, Julia Delahousse,Kaissa Ouali,Aurelien Marabelle,Yohann Loriot,Santiago Ponce,Stephane Champiat,Sophie Broutin,Francois-Xavier Danlos

Journal for ImmunoTherapy of Cancerno. 5 (2024)

引用0浏览0引用

Abstract 6438: Subcutaneous fat mass predicts progression-free survival in patients treated with antibody-drug-conjugates in early-phase clinical trials

Matthieu Delaye,Littisha Lawrance,Younes Belkouchi, Felix Wirth,Pierre Decazes,Alexandre Bône,Kaïssa Ouali,Antoine Hollebecque,Cristina Smolenschi,Rastislav Bahleda,Anas Gazzah,Stéphane Champiat,

Cancer Research（2024）

引用0浏览0引用

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors

Stephane Champiat,Francois-Xavier Danlos,Aurélien Marabelle, Yohann Loriot, Julia Delahousse,Kaïssa Ouali,Santiago Ponce, Laurent Mathiot, David Combarel, Justin Cagnat, Sophie Broutin

Journal for ImmunoTherapy of Cancerno. 5 (2024)

引用0浏览0引用

Antibody drug conjugates in older patients: State of the art

Layal Rached,Arthur Geraud, Maxime Frelaut, Zoe A. P. Thomas,Vincent Goldschmidt, Geoffroy Beraud-Chaulet, Celine Nagera-Lazarovici,Francois -Xavier Danlos,Clemence Henon,Claudia Parisi,Anas Gazzah,Rastilav Bahleda,

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2024): 104212-104212

引用0浏览0WOS引用

Abstract CT084: A phase 1 study of LY4101174 (ETx-22), an antibody-drug conjugate targeting nectin-4, in patients with advanced or metastatic urothelial cancer and other solid tumors (trial in progress)

Jonathan Rosenberg,Renaud Sabatier, Armelle Viceneux,Thibault de La Motte Rouge,Stephane Champiat, Loic Lebellec, Philippe Barthélémy,Guru Sonpavde, Xin Gao,Scot Niglio,Tian Zhang, Craig Gedye,

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Abstract 6406: Clinical and translational results of the academic ARIANES Phase 2 basket study: Longitudinal single-cell analysis of patient tumors identifies biological correlates of response to PARP inhibitors and anti-PD-L1 therapy

Julien Vibert,Clémence Hénon,Lambros Tselikas,Baptiste Bonnet,Arnaud Pagès,Alice Bernard-Tessier,Léo Colmet-Daage,Roman Chabanon,Nicolas Dorvault,Clémence Astier,Anas Gazzah, Aurore Jeanson,

Cancer Researchno. 6_Supplement (2024): 6406-6406

引用0浏览0引用

Phase II study to determine the anti-tumor activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in esophageal cancer

Hans Prenen,Sanjeev Deva,Bhumsuk Keam,Colin R Lindsay,Iwona Lugowska, James C Yang,Federico Longo, Maria de Miguel,Mariano Ponz-Sarvise,Myung-Ju Ahn,Mahmut Gumus,Stephane Champiat,

Clinical cancer research : an official journal of the American Association for Cancer Research (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn